Compare
Cerence Inc. vs C3.ai, Inc. vs Definitive Healthcare Corp. vs GCL Global Holdings Ltd
| Latest fiscal year | Cerence Inc. CRNC | C3.ai, Inc. AI | Definitive Healthcare Corp. DH | GCL Global Holdings Ltd GCL |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2026-04-30 | 2025-12-31 | 2026-03-31 |
| Revenue | $251.78M | $250.27M | $241.52M | $238.92M |
| Revenue growth (YoY) | -24.0% | -35.7% | -4.2% | +68.2% |
| Gross margin | 72.7% | 30.9% | 75.9% | 10.3% |
| Operating margin | -0.9% | -199.2% | -92.9% | -5.6% |
| Net margin | -7.4% | -187.9% | -57.5% | -10.5% |
| Net income | -$18.71M | -$470.37M | -$138.93M | -$25.00M |
| EPS (Diluted) | -$0.43 | -$3.35 | -$1.30 | -$0.20 |
| Operating cash flow | $61.17M | -$190.23M | $53.78M | -$10.50M |
| Free cash flow | $46.82M | -$192.14M | $37.06M | -$11.65M |
| Cash & equivalents | n/a | $66.20M | $163.63M | $36.58M |
| Total assets | $630.59M | $816.27M | $735.49M | $183.18M |
| Total liabilities | $479.92M | $162.52M | $356.50M | $142.29M |
| Shareholders' equity | $150.68M | $653.75M | $378.99M | $40.90M |
| Return on year-end equity | -12.4% | -71.9% | -36.7% | -61.1% |
| Shares outstanding | 43.37M | n/a | n/a | 128.01M |
Revenue, most recent five fiscal years
| Fiscal year | Cerence Inc. | C3.ai, Inc. | Definitive Healthcare Corp. | GCL Global Holdings Ltd |
|---|---|---|---|---|
| Latest | $251.78M Ended 2025-09-30 | $250.27M Ended 2026-04-30 | $241.52M Ended 2025-12-31 | $238.92M Ended 2026-03-31 |
| 1 year earlier | $331.50M Ended 2024-09-30 | $389.06M Ended 2025-04-30 | $252.20M Ended 2024-12-31 | $142.07M Ended 2025-03-31 |
| 2 years earlier | $294.48M Ended 2023-09-30 | $310.58M Ended 2024-04-30 | $251.41M Ended 2023-12-31 | $97.53M Ended 2024-03-31 |
| 3 years earlier | $327.89M Ended 2022-09-30 | $266.80M Ended 2023-04-30 | $222.65M Ended 2022-12-31 | $77.44M Ended 2023-03-31 |
| 4 years earlier | $387.18M Ended 2021-09-30 | $252.76M Ended 2022-04-30 | $166.15M Ended 2021-12-31 | n/a |